Michael Perry is a Partner in the Antitrust and Competition Practice at Baker Botts. He focuses on advising clients in merger and non-merger antitrust investigations before the Federal Trade Commission and the U.S. Department of Justice, and in complex private and government antitrust litigation. Mr. Perry has particular experience in the healthcare, life sciences, and technology sectors, including issues involving the intersection of antitrust and intellectual property law.
Mr. Perry recently joined the firm after serving as Counsel to the Director of the Federal Trade Commission's Bureau of Competition from 2015 to 2016. In that front-office role, he was directly involved in many of the agency's most important antitrust enforcement actions, including both merger and non-merger matters. He played an integral role in the FTC's challenge to the proposed Sysco/U.S. Foods merger and other high-profile cases such as FTC v. Actavis, FTC v. Cephalon, FTC v. Advocate Health, and FTC v. St. Luke's Health System.
Prior to joining the front-office, Mr. Perry served as an Attorney in the FTC’s Health Care Division from 2010 to 2015, where he helped lead the agency's enforcement efforts in the pharmaceutical and health care sectors.
A graduate of Stanford Law School, Mr. Perry worked in private practice before serving as a law clerk for the Honorable Allyne R. Ross (E.D. N.Y.), and the Honorable Michael A. Chagares (3d Cir.). Mr. Perry currently serves in the leadership of the Antitrust section of the American Bar Association as an editor of the Antitrust Law Journal. He has been recognized in Global Competition Review's review of the Washington, D.C. antitrust bar, in which Baker Botts' Antitrust Practice was ranked as one of the leading "Outstanding" firms (2017), and by The Legal 500 U.S. (2017).